SproutNews logo

Nanoparticles Market in Biotechnology and Pharmaceutical Sectors 2017 Global Market Expected to Grow at CAGR 21.72 % and Forecast to 2021

The report provides in depth study of “Nanoparticles” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization

pune, India – November 28, 2017 /MarketersMedia/

Nanoparticles Market Analysis And Forecast

About Nanoparticles

Nanoparticles are sub-nanosized colloidal structures composed of synthetic or semi-synthetic polymers. These are used in biotechnology and pharmaceutical sectors for studying biological systems for diagnosing diseases and focusing on treatment at the molecular level. The properties of many conventional materials alter when formed from nanoparticles, the reason being nanoparticles have a greater surface area per weight than larger particles, making them more reactive to other molecules

Technavio’s analysts forecast the global nanoparticles market in biotechnology and pharmaceutical sectors to grow at a CAGR of 21.72% during the period 2017-2021.

Covered in this report 
The report covers the present scenario and the growth prospects of the global nanoparticles market in biotechnology and pharmaceutical sectors for 2017-2021. To calculate the market size, the report considers the revenue generated from the retail sales of nanoparticles in the aforesaid sectors.

The market is divided into the following segments based on geography: 
• Americas 
• APAC 
• EMEA

Technavio’s report, Global Nanoparticles Market in Biotechnology and Pharmaceutical Sectors 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors 
• F. Hoffmann-La Roche 
• GE Healthcare 
• Merck 
• Novartis 
Other prominent vendors 
• AMAG Pharmaceuticals 
• Amgen 
• Bausch & Lomb 
• Biogen 
• Celgene 
• Gilead 
• Ipsen 
• Leadiant Biosciences 
• nanoComposix 
• Pacira Pharmaceuticals 
• Pfizer 
• Shire 
• UCB 
Market driver 
• Rising R&D expenditure in pharmaceutical and biotechnology sectors 
• For a full, detailed list, view our report

Market challenge 
• Challenges in development of nanoparticles for therapeutics 
• For a full, detailed list, view our report

Market trend 
• Increasing demand for nanoparticles in stem cell therapy 
• For a full, detailed list, view our report

Key questions answered in this report 
• What will the market size be in 2021 and what will the growth rate be? 
• What are the key market trends? 
• What is driving this market? 
• What are the challenges to market growth? 
• Who are the key vendors in this market space?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

 

Request For Sample Report @ https://www.wiseguyreports.com/sample-request/2534455-global-nanoparticles-market-in-biotechnology-and-pharmaceutical-sectors-2017-2021                                         

                                                        

Table of Contents:

PART 01: EXECUTIVE SUMMARY 
PART 02: SCOPE OF THE REPORT 
PART 03: RESEARCH METHODOLOGY 
PART 04: INTRODUCTION 
• Market outline 
PART 05: MARKET LANDSCAPE 
• Market size and forecast 
• Five forces analysis 
PART 06: MARKET SEGMENTATION BY END-USER 
• Comparison by end-user 
• Biotechnology 
• Pharmaceutical 
• Market opportunity by end-user 
PART 07: REGIONAL LANDSCAPE 
• Regional comparison 
• Nanoparticles market in biotechnology and pharmaceutical sectors in Americas 
• Nanoparticles market in biotechnology and pharmaceutical sectors in EMEA 
• Nanoparticles market in biotechnology and pharmaceutical sectors in APAC 
• Market opportunity 
PART 08: DECISION FRAMEWORK 
PART 09: DRIVERS AND CHALLENGES 
• Market drivers 
• Market challenges 
PART 10: MARKET TRENDS 
• Increasing demand for nanoparticles in stem cell therapy 
• Increasing prevalence of chronic diseases 
• Increasing use of gold nanoparticles 
PART 11: VENDOR LANDSCAPE 
• Competitive scenario 
• Investment opportunity 
PART 12: VENDOR ANALYSIS 
• Vendor overview 
• Merck 
• F. Hoffmann-La Roche 
• GE Healthcare 
• Novartis 

 Continued…….

 

Enquiry Before Buy @ https://www.wiseguyreports.com/enquiry/2534455-global-nanoparticles-market-in-biotechnology-and-pharmaceutical-sectors-2017-2021                                                                      

                                                                                                                                                             

Contact Info:
Name: norah trent
Email: sales@wiseguyreports.com
Organization: WiseGuyResearch Consultants Pvt Ltd
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar Pune – 411028 Maharashtra, India
Phone: +1 (339) 368 6938

Source URL: https://marketersmedia.com/nanoparticles-market-in-biotechnology-and-pharmaceutical-sectors-2017-global-market-expected-to-grow-at-cagr-21-72-and-forecast-to-2021/270564

For more information, please visit https://www.wiseguyreports.com

Source: MarketersMedia

Release ID: 270564

Go Top